We found CD30L expression in tissue-resident cells, tumor cells and immune cells in the cohorts treated with WT and Pd1−/− Treg cells (Supplementary Fig. 7e and Supplementary Table 4f). This evidence concerns the gene TNFSF8 and neoplasm.